Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2007-08-07
2007-08-07
Haddad, Maher M. (Department: 1644)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
Reexamination Certificate
active
10733646
ABSTRACT:
The present invention relates to a novel human Ependymin protein which is a member of the ependymin family. In particular, isolated nucleic acid molecules are provided encoding the human Ependymin protein. Ependymin polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of Ependymin activity. Also provided are diagnostic methods for detecting nervous system-related disorders and therapeutic methods for treating nervous system-related disorders.
REFERENCES:
patent: 5545719 (1996-08-01), Shashoua et al.
patent: 6489138 (2002-12-01), Ebner et al.
patent: 6613887 (2003-09-01), Ogi et al.
patent: 6683161 (2004-01-01), Ebner et al.
patent: 2004/0014947 (2004-01-01), Ogi et al.
patent: WO 98/11130 (1998-03-01), None
Adams et al. “Initial assessment of human gene diversity and expression patterns based upon 83 million nucleotides of cDNA sequence.” Nature 377 (Supp. 6547):3-17 (1995).
Hoffman, W. “Ependymins and their potential role in nuroplasticity and regeneration: calcium-binding meningeal glycoproteins of the cerebrospinal fluid and extracellular matrix.” Int. J. Biochem (26)5-607-619 (1994).
Genbank Accession No. AA131797, Hiller et al. (Nov. 27, 1996).
Genbank Accession No. AA131847, Hillier et al. (Nov. 27, 1996).
Genbank Accession No. AA157807, Hillier et al. (Dec. 16, 1996).
Genbank Accession No. AA209496, Hillier et al. (Jan. 29, 1997).
Genbank Accession No. AA322665, Adams et al., (Apr. 14, 1997).
Genbank Accession No. AA325686 Adams et al. (Apr. 20, 1997).
Genbank Accession No. AA420449, (Oct. 16, 1997).
Genbank Accession No. AA442737, Hillier et al. (Jun. 3, 1997).
Genbank Accession No. A659548, (Nov. 5, 1997).
Genbank Accession No. C04855, Tanaka et al. (Jul. 30, 1996).
Genbank Accession No. F05414, Auffray et al., (Feb. 19, 1995).
Genbank Accession No. N47444, Hillier et al. (Feb. 14, 1996).
Genbank Accession No. N47445, Hillier et al. (Feb. 14, 1996).
Genbank Accession No. N49194, Hillier et al. (Feb. 14, 1996).
Genbank Accession No. N50249, Hillier et al. (Feb. 14, 1996).
Genbank Accession No. N53580, Hillier et al. (Jan. 28, 1997).
Genbank Accession No. W02349, Hillier et al., (Apr. 18, 1996).
Genbank Accession No. W58404, Hillier et al. (Oct. 15, 1996).
Genbank Accession No. W58478 (Hillier et al.) (Oct. 15, 1996).
Ogi et al., “Human ependymin-like protein encoding Cdna” Sequence homology search in Geneseq Database, Accession No. V07200, Nov. 6, 1998.
Ogi et al., “Human ependymin-like protein” Nov. 6, 1998, Database :A—Geneseq—101002, Accession No: AAW51119, alignment SEQ ID No:2(1-224).
Ogi et al., “Human ependymin-like protein” Nov. 6, 1998, Database :A—Geneseq—101002, Accession No: AAW51119, alignment SEQ ID No:2(2-224).
Ogi et al., “Human ependymin-like protein” Nov. 6, 1998, Database :A—Geneseq—101002, Accession No: AAW51119, alignment SEQ ID No:2(38-224).
Ogi et al., “Human ependymin-like protein” Nov. 6, 1998, Database :A—Geneseq—101002, Accession No: AAW51119, alignment SEQ ID No:2(41-224).
Ogi et al., “Human ependymin-like protein” Nov. 6, 1998, Database :A—Geneseq—101002, Accession No: AAW51119, alignment SEQ ID No:2(1-174).
Ogi et al., “Human ependymin-like protein” Nov. 6, 1998, Database :A—Geneseq—101002, Accession No: AAW51119, alignment SEQ ID No:2(41-174).
Ogi et al., “Human ependymin-like protein” Nov. 6, 1998, Database :A—Geneseq—101002, Accession No: AAW51119, alignment SEQ ID No:2(1-9).
Ogi et al., “Human ependymin-like protein” Nov. 6, 1998, Database :A—Geneseq—101002, Accession No: AAW51119, alignment SEQ ID No:2(8-16).
Ogi et al., “Human ependymin-like protein” Nov. 6, 1998, Database :A—Geneseq—101002, Accession No: AAW51119, alignment SEQ ID No:2(19-27).
Ogi et al., “Human ependymin-like protein” Nov. 6, 1998, Database :A—Geneseq—101002, Accession No: AAW51119, alignment SEQ ID No:2(69-77).
Ogi et al., “Human ependymin-like protein” Nov. 6, 1998, Database :A—Geneseq—101002, Accession No: AAW51119, alignment SEQ ID No.2(86-107).
Ogi et al., “Human ependymin-like protein” Nov. 6, 1998, Database :A—Geneseq—101002, Accession No: AAW51119, alignment SEQ ID No:2(113-123).
Ogi et al., “Human ependymin-like protein” Nov. 6, 1998, Database :A—Geneseq—101002, Accession No: AAW51119, alignment SEQ ID No:2(131-139).
Ogi et al., “Human ependymin-like protein” Nov. 6, 1998, Database :A—Geneseq—101002, Accession No: AAW51119, alignment SEQ ID No:2(159-167).
Ebner Reinhard
Ruben Steven M.
Haddad Maher M.
Human Genome Sciences Inc.
LandOfFree
Antibodies to human Ependymin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibodies to human Ependymin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies to human Ependymin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3831507